Cargando…
Mass spectrometry-based proteomics techniques and their application in ovarian cancer research
Ovarian cancer has emerged as one of the leading cause of gynecological malignancies. So far, the measurement of CA125 and HE4 concentrations in blood and transvaginal ultrasound examination are essential ovarian cancer diagnostic methods. However, their sensitivity and specificity are still not suf...
Autores principales: | Swiatly, Agata, Plewa, Szymon, Matysiak, Jan, Kokot, Zenon J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6166298/ https://www.ncbi.nlm.nih.gov/pubmed/30270814 http://dx.doi.org/10.1186/s13048-018-0460-6 |
Ejemplares similares
-
Understanding Ovarian Cancer: iTRAQ-Based Proteomics for Biomarker Discovery
por: Swiatly, Agata, et al.
Publicado: (2018) -
MALDI-TOF-MS analysis in discovery and identification of serum proteomic patterns of ovarian cancer
por: Swiatly, Agata, et al.
Publicado: (2017) -
Mass spectrometry imaging in gynecological cancers: the best is yet to come
por: Pietkiewicz, Dagmara, et al.
Publicado: (2022) -
Diagnostic Value of Serum Angiogenesis Markers in Ovarian Cancer Using Multiplex Immunoassay
por: Horala, Agnieszka, et al.
Publicado: (2017) -
Influence of Honeybee Sting on Peptidome Profile in Human Serum
por: Matysiak, Jan, et al.
Publicado: (2015)